Biotech Thursday Biobusiness
21-09-2017 15:00 tot 21-09-2017 18:00 (Europe/Amsterdam)
By clicking register now, you accept HollandBIO's terms and conditions.
HollandBIO is excited to announce three seasoned biotech entrepreneurs to present at our next Biotech Thursday: Pharming CEO Sijmen de Vries, Fibriant CEO Jaap Koopman and Probiodrug CEO Konrad Glund. Over the last months, their companies made headlines, reporting on exciting progress.
Pharming’s journey has been – and still is – an unequalled rollercoaster ride. While the route forward planned out by CEO Sijmen de Vries initially met with scepticism, the company today is doing better than ever before. For the first time in its long history, Pharming actually is profitable. We are thrilled Sijmen de Vries will join our Biotech Thursday to inspire and educate us with his fascinating story.
In June, Probiodrug presented encouraging early-stage results of its PQ912 trial. The Amsterdam-listed company boldly works on a therapy for Alzheimer’s Disease, seemingly unconcerned by the dreaded image the devastating disease gained after numerous failed drug trials. CEO Konrad Glund will enlighten us on how a German company ended up at the Amsterdam Stock Exchange, on Probiodrug’s progress to date and, of course, the challenging road that lies ahead.
After the successful acquisition of ProFibrix in 2013 by The Medicines Company, Jaap Koopman founded Fibriant in 2015. The company has a strong R&D focus and aims to create and develop new innovative healthcare solutions all based on the unique properties of human fibrinogen. We are excited that Jaap will share his experience with us.
In conclusion: don’t miss this unique chance to learn from these biotech headliners and the opportunity to ask them all about the secrets of their success.
|15.00 hr||Welcome, Coffee and Tea |
|17.00 hr||Drinks |
For more information contact HollandBIO's Fabian